Status:
SUSPENDED
Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment
Lead Sponsor:
Catalysis SL
Conditions:
Chronic Inflammatory Syndrome
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to determine whether Viusid administration improves malnutrition, atherosclerosis, erythropoietin response and the frequency of infection episodes in subjects with Chronic ...
Eligibility Criteria
Inclusion
- Subjects with chronic terminal nephropathy under hemodialysis treatment for at least 3 months
- Signed informed consent
Exclusion
- Patients with chronic terminal nephropathy previously treated with peritoneal dialysis
- Receptors of a renal graft
- Patients with malignant neoplastic conditions
- Pregnant women
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT00978224
Start Date
October 1 2009
End Date
September 1 2011
Last Update
July 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Nephrology "Dr. Abelardo Buch López"
Havana, Cuba, 10400